OnabotulinumtoxinA Demonstrates Similar Improvements in Urinary Incontinence and Quality of Life Regardless of the Use of Clean Intermittent Catheterisation or the Presence of Urinary Tract Infection in Patients with Overactive Bladder

Everaert K1, Gruenenfelder J2, Schulte-Baukloh H3, Guard S4, Zheng Y5, Sussman D6

Abstract Category

Urodynamics

Abstract 327
Lower Urinary Tract Symptoms in Women 1
Scientific Podium Poster Session 20
Wednesday 22nd October 2014
15:15 - 15:20
Room 3
Incontinence Overactive Bladder Quality of Life (QoL) Voiding Dysfunction Clinical Trial
1. Ghent University Hospital, Gent, Belgium, 2. Orange County Urology Associates, Laguna Hills, CA, USA, 3. St. Hedwig-Krankenhaus, Berlin, Germany, 4. Allergan Ltd, Marlow, United Kingdom, 5. Allergan Inc, Bridgewater, NJ, USA, 6. Rowan University School of Osteopathic Medicine, Stratford, NJ, USA
Presenter
K

Karel Everaert

Links

Abstract

18/04/2024 01:08:50